9-3PG Treatment of Small Airway Disease: When, How, How Long?

Saturday, 6 December 2014: 11:35 - 11:50
Sala C (Sul America)

Peter Howarth , Reader in Medicine and Honorary Consultant Physician, Southampton, United Kingdom

Learning Objectives:
At the end of this session you should

- appreciate the involvement of the small airways in asthma

- appreciate the importance of inhaled particle size in targetting drugs to the small airways

- have insight into the effect of ultrafine particle inhaler therapy on clinical and biological outcomes in asthma